Dr. Seung T Lee
Claim this profileUniversity of Maryland
Studies Lymphoma
Studies Peripheral T-Cell Lymphoma
8 reported clinical trials
11 drugs studied
Area of expertise
1Lymphoma
CD19 positive
KIR3DL2 positive
EZH2 positive
2Peripheral T-Cell Lymphoma
KIR3DL2 positive
Affiliated Hospitals
Clinical Trials Seung T Lee is currently running
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting1 award Phase 34 criteria
IKS03
for B-Cell Lymphoma
This first-in-human study will evaluate the recommended dose for further clinical development, safety, tolerability, antineoplastic activity, immunogenicity, pharmacokinetics and pharmacodynamics of IKS03, a CD19 targeting antibody-drug conjugate, in patients with advanced B cell non-Hodgkin lymphoma (NHL).
Recruiting1 award Phase 1
More about Seung T Lee
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Seung T Lee has experience with
- Rituximab
- Brentuximab Vedotin
- Lenalidomide
- LOXO-305
- Lacutamab
- Placebo
Breakdown of trials Seung T Lee has run
Lymphoma
Peripheral T-Cell Lymphoma
T-Cell Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Seung T Lee specialize in?
Seung T Lee focuses on Lymphoma and Peripheral T-Cell Lymphoma. In particular, much of their work with Lymphoma has involved CD19 positive patients, or patients who are KIR3DL2 positive.
Is Seung T Lee currently recruiting for clinical trials?
Yes, Seung T Lee is currently recruiting for 2 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Seung T Lee has studied deeply?
Yes, Seung T Lee has studied treatments such as Rituximab, Brentuximab Vedotin, Lenalidomide.
What is the best way to schedule an appointment with Seung T Lee?
Apply for one of the trials that Seung T Lee is conducting.
What is the office address of Seung T Lee?
The office of Seung T Lee is located at: University of Maryland, Baltimore, Maryland 21201 United States. This is the address for their practice at the University of Maryland.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.